SELECTIS HEALTH INC. GBCS overview

RESEARCH TRIANGLE PARK, N.C., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK TM (a unique formulation of sodium thiosulfate (STS)) for the prevention of platinum-induced ototoxicity in pediatric patients, today announced that Rosty Raykov, Chief Executive Officer of Fennec, will present at the Cantor Fitzgerald Global Healthcare Conference in New York on Friday, October 4 th , at 1:45...

Stealth Biotherapeutics to Present at the 2019 Cantor Global Healthcare Conference PR Newswire BOSTON, Oct. 1, 2019 BOSTON , Oct. 1, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie McCarthy , Chief Executive Officer, will present at the 2019 Cantor Global Healthcare Conference on...

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced that Chief Executive Officer Edward M. Kaye, M.D., will present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 at 10:05 a.m. Eastern time in New York, New York. A live audio webcast of the presentation will be available on the Investors & Media section of Stoke’s...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Michael Nally, Chief Marketing Officer for Merck, is scheduled to present during a fireside chat at the Cantor Fitzgerald 2019 Annual Global Healthcare Conference in New York on Wednesday, Oct. 2, at 2:25 p.m. EDT. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at...

CAMBRIDGE, Mass., Sept. 27, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, today announced that Ian Somaiya, Chief Financial Officer of TCR 2 Therapeutics, will present a company overview at the 2019 Cantor Global Healthcare Conference on October 4, 2019 at 12:00pm ET in New York, NY. A live webcast of the presentation will be available on the...

Correvio to Present at the 2019 Cantor Global Healthcare Conference PR Newswire VANCOUVER, Sept. 27, 2019 NASDAQ: CORV TSX: CORV VANCOUVER , Sept. 27, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Mark H.N. Corrigan , MD, Chief Executive Officer of Correvio, will present at the 2019 Cantor Global Healthcare Conference. The fireside chat will take place at the...

Aridis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference PR Newswire SAN JOSE, Calif., Sept. 27, 2019 SAN JOSE, Calif. , Sept. 27, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that Vu Truong , Ph.D., Chief Executive Officer, will present at the 2019 Cantor Global Healthcare Conference...

Luminex Corporation to Present at the Cantor Global Healthcare Conference on October 2, 2019 PR Newswire AUSTIN, Texas, Sept. 26, 2019 AUSTIN, Texas , Sept. 26, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir , President and Chief Executive Officer, and Harriss Currie , Senior Vice President of Finance and CFO, will participate in investor meetings and present at the Cantor Global Healthcare Conference on Wednesday, October 2, 2019 in New York, NY . A...